<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2077-2161</journal-id>
<journal-title><![CDATA[Ajayu Órgano de Difusión Científica del Departamento de Psicología UCBSP]]></journal-title>
<abbrev-journal-title><![CDATA[Ajayu]]></abbrev-journal-title>
<issn>2077-2161</issn>
<publisher>
<publisher-name><![CDATA[Universidad Cátolica Boliviana "San Pablo"]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2077-21612023000200148</article-id>
<article-id pub-id-type="doi">10.35319/ajayu.212215</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[¿Qué es la neuromejora? Hacia una comprensión enactiva del fenómeno]]></article-title>
<article-title xml:lang="en"><![CDATA[What is neuroenhancement? Towards an enactive understanding of the phenomenon]]></article-title>
<article-title xml:lang="pt"><![CDATA[¿O que é neuroenhancement? Para uma compreensão enactive do fenômeno]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pinto-Venegas]]></surname>
<given-names><![CDATA[Juan Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Diego Portales Facultad de Psicología ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Chile</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2023</year>
</pub-date>
<volume>21</volume>
<numero>2</numero>
<fpage>148</fpage>
<lpage>155</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_arttext&amp;pid=S2077-21612023000200148&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_abstract&amp;pid=S2077-21612023000200148&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.bo/scielo.php?script=sci_pdf&amp;pid=S2077-21612023000200148&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Durante las últimas décadas, el consumo de psicofármacos ha aumentado sostenidamente en la población mundial. Particularmente en Latinoamérica, es observable un aumento del consumo de drogas ilícitas, entre ellos de psicofármacos, principalmente en población universitaria vía automedicación Dentro de las prácticas de automedicación en el mundo universitario encontramos distintos usos sociales y subjetivos destacando entre ellos, el uso de fármacos psicoestimulantes con el fin de potenciar el desempeño académico, práctica llamada neuromejora. Este modo de uso del fármaco pone en cuestión la brecha epistemológica entre las ciencias biológicas y las ciencias sociales, ya que su comprensión, no es reductible a ninguno de estos paradigmas. Las acciones humanas, siempre se dan en circunstancias físicas y culturales, en donde el otro y la vida social, afectan la propia percepción y acción, en este sentido, la pregunta sobre qué es la neuromejora, será posible de abordar desde una epistemología que proponga un marco de comprensión e intervención, que tenga en cuenta el carácter complejo y dinámico de la misma, al igual que, de un trabajo científico e interdisciplinar.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT During the last decades, the consumption of psychotropic drugs has been sustained in the world population. Particularly in Latin America, an increase in the consumption of illicit drugs is observable, including psychoactive drugs, mainly in the university population. Self-medication Within the self-medication practices in the university world, we find different social and subjective uses, highlighting among them the use of psychostimulant drugs. in order to enhance academic performance, a practice called neuroenhancement. This way of using the drug calls into question the epistemological gap between the biological sciences and the social sciences, since its understanding is not reducible to any of these paradigms. Human actions always occur in physical and cultural circumstances, where the other and social life, reduce one's own perception and action, in this sense, the question about what neuroenhancement would be, will be possible to address from an epistemology that proposes a framework of understanding and intervention, which takes into account its complex and dynamic nature, as well as scientific and interdisciplinary work.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO Nas últimas décadas, o consumo de drogas psicoativas tem aumentado constantemente na população mundial. Particularmente na América Latina há um aumento no consumo de drogas ilícitas, inclusive psicotrópicas, principalmente na população universitária por meio da automedicação. Dentro das práticas de automedicação no mundo universitário encontramos diferentes usos sociais e subjetivos, destacando-se entre eles o uso de drogas psicoestimulantes para melhorar o desempenho acadêmico, prática denominada neuroenhancement. Esta forma de usar a droga põe em causa o fosso epistemológico entre as ciências biológicas e as ciências sociais, uma vez que a sua compreensão não é redutível a nenhum destes paradigmas. As ações humanas ocorrem sempre em circunstâncias físicas e culturais, onde o outro e a vida social afetam a sua própria percepção e ação. , que leva em consideração sua natureza complexa e dinâmica, bem como o trabalho científico e interdisciplinar.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[neuroenhancement]]></kwd>
<kwd lng="en"><![CDATA[epistemology]]></kwd>
<kwd lng="es"><![CDATA[neuromejora]]></kwd>
<kwd lng="es"><![CDATA[epistemologia]]></kwd>
<kwd lng="pt"><![CDATA[neuroaprimoramiento]]></kwd>
<kwd lng="pt"><![CDATA[epistemología]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Araujo]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Martuccelli]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La escuela y la cuestión del mérito. Reflexiones desde la experiencia chilena]]></article-title>
<source><![CDATA[Educação e Pesquisa]]></source>
<year>2015</year>
<volume>41</volume>
<page-range>1503-20</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bard]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Gaskell]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Allansdottir]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Bottom Up Ethics - Neuroenhancement in Education and Employment]]></article-title>
<source><![CDATA[Neuroethics]]></source>
<year>2018</year>
<volume>11</volume>
<page-range>309-22</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ortega]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metilfenidato e Aprimoramento Cognitivo Farmacológico: representações sociais de universitários]]></article-title>
<source><![CDATA[Saúde e Sociedade]]></source>
<year>2011</year>
<volume>20</volume>
<page-range>350-62</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="">
<collab>Comisión Interamericana para el Control de Abuso de Drogas</collab>
<source><![CDATA[CICAD]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Di Paolo]]></surname>
<given-names><![CDATA[E. A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The enactive conception of life]]></article-title>
<source><![CDATA[The Oxford handbook of cognition: Embodied, embedded, enactive and extended]]></source>
<year>2018</year>
<page-range>71-94</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="book">
<collab>European Monitoring Centre for Drugs and Drug Addiction</collab>
<source><![CDATA[Impact of COVID-19 on patterns of drug use and drug-related harms in Europe]]></source>
<year>2020</year>
<publisher-name><![CDATA[EMCDDA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Forlini]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Schildmann]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Roser]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Beranek]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Vollmann]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Knowledge, Experiences and Views of German University Students Toward Neuroenhancement: An Empirical-Ethical Analysis]]></article-title>
<source><![CDATA[Neuroethics]]></source>
<year>2014</year>
<volume>8</volume>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallagher]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Decentering the brain. Embodied cognition and the critique of neurocentrism and narrow-minded philosophy of mind]]></article-title>
<source><![CDATA[Constructivist Foundations]]></source>
<year>2018</year>
<volume>14</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-21</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[Á.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspirar a una universidad selectiva y concretar las aspiraciones: factores determinantes]]></article-title>
<source><![CDATA[Calidad en la Educación]]></source>
<year>2018</year>
<numero>40</numero>
<issue>40</issue>
<page-range>236-67</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grasso-Cladera]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Costa-Cordella]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fuchs]]></surname>
<given-names><![CDATA[NF]]></given-names>
</name>
<name>
<surname><![CDATA[Parada]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Mobile Brain/Body Imaging: Challenges and opportunities for the implementation of research programs based on the 4E perspective to cognition]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jenkins]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychopharmaceutical self and imaginary in the social field of psychiatric treatment]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Jenkins]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Pharmaceutical Self: The global shaping of experience in an age of psychopharmacology]]></source>
<year>2011</year>
<publisher-name><![CDATA[School for Advanced Research Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="book">
<collab>National Institute on Drug Abuse</collab>
<source><![CDATA[Principles of Drug Addiction Treatment. A research- Based Guide]]></source>
<year>2012</year>
<edition>3</edition>
<publisher-name><![CDATA[NIH Publication]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lemieux]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[La sociologie pragmatique]]></source>
<year>2018</year>
<publisher-name><![CDATA[La Découverte]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[O&#8217;Connor]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Nagel]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Neuro-Enhancement Practices across the Lifecourse: Exploring the Roles of Relationality and Individualism]]></source>
<year>2017</year>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parada]]></surname>
<given-names><![CDATA[F. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[If Neuroscience Needs Behavior, What Does Psychology Need?]]></article-title>
<source><![CDATA[Frontiers in psychology]]></source>
<year>2018</year>
<volume>9</volume>
<page-range>433</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Kelleher]]></surname>
<given-names><![CDATA[K.J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neuroenhancement in young people: Proposal for research, policy, and clinical management]]></article-title>
<source><![CDATA[Ajob Neuroscience]]></source>
<year>2010</year>
<volume>1</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-16</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[A.M. Filipe]]></surname>
<given-names><![CDATA[I. Bard]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Globalization and cognitive enhancement: Emerging social and ethical challenges for ADHD clinicians]]></article-title>
<source><![CDATA[Current Psychiatry Reports]]></source>
<year>2013</year>
<volume>15</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>385</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Bard]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Jackson]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Robust Resilience and Substantial Interest: A Survey of Pharmacological Cognitive Enhancement among University Students in the UK and Ireland]]></article-title>
<source><![CDATA[PLoS ONE]]></source>
<year>2014</year>
<volume>9</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vargo]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Petróczi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[It Was Me on a Good Day: Exploring the Smart Drug Use Phenomenon in England]]></article-title>
<source><![CDATA[Front Psychol]]></source>
<year>2016</year>
<volume>7</volume>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
